Cargando…

Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial

IMPORTANCE: The ability to predict neurodevelopmental impairment (NDI) for infants diagnosed with hypoxic ischemic encephalopathy (HIE) is important for parental guidance and clinical treatment as well as for stratification of patients for future neurotherapeutic studies. OBJECTIVES: To examine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juul, Sandra E., Voldal, Emily, Comstock, Bryan A., Massaro, An N., Bammler, Theo K., Mayock, Dennis E., Heagerty, Patrick J., Wu, Yvonne W., Numis, Adam L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329214/ https://www.ncbi.nlm.nih.gov/pubmed/37418263 http://dx.doi.org/10.1001/jamanetworkopen.2023.22131

Ejemplares similares

High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2017)

Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
por: Glass, Hannah C., et al.
Publicado: (2023)

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
por: Wood, Thomas R., et al.
Publicado: (2021)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?
por: Wu, Yvonne W., et al.
Publicado: (2023)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
por: Law, Janessa B., et al.
Publicado: (2021)

Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
por: Vu, Phuong T., et al.
Publicado: (2021)

Effect of erythropoietin combined with hypothermia on serum tau protein levels and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy
por: Lv, Hong-yan, et al.
Publicado: (2017)

Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns
por: Valentine, Gregory, et al.
Publicado: (2023)

Seizure burden and neurodevelopmental outcome in neonates with hypoxic–ischemic encephalopathy
por: Kharoshankaya, Liudmila, et al.
Publicado: (2016)

Association of Hospital Resource Utilization With Neurodevelopmental Outcomes in Neonates With Hypoxic-Ischemic Encephalopathy
por: Quinones Cardona, Vilmaris, et al.
Publicado: (2023)

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2022)

Contemporary Definitions of Infant Growth Failure and Neurodevelopmental and Behavioral Outcomes in Extremely Premature Infants at Two Years of Age
por: Strobel, Katie, et al.
Publicado: (2023)

Evaluating Neuroprotective Effects of Uridine, Erythropoietin, and Therapeutic Hypothermia in a Ferret Model of Inflammation-Sensitized Hypoxic-Ischemic Encephalopathy
por: Corry, Kylie A., et al.
Publicado: (2021)

Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research
por: Oorschot, Dorothy E., et al.
Publicado: (2020)

Erythropoietin may improve the Outcome in Infants with Moderate to Severe Hypoxic Ischemic Encephalopathy
por: Al-Salam, Zakariya
Publicado: (2013)

Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches
por: Juul, Sandra E., et al.
Publicado: (2022)

Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation
por: Wisnowski, Jessica L, et al.
Publicado: (2021)

Mild hypoxic-ischemic encephalopathy (HIE): timing and pattern of MRI brain injury
por: Li, Yi, et al.
Publicado: (2022)

Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy
por: Diao, Min, et al.
Publicado: (2019)

The effect of erythropoietin on neonatal hypoxic-ischemic encephalopathy: An updated meta-analysis of randomized control trials
por: Pan, Jing-Jing, et al.
Publicado: (2023)

Whole genome methylation and transcriptome analyses to identify risk for cerebral palsy (CP) in extremely low gestational age neonates (ELGAN)
por: Massaro, An N., et al.
Publicado: (2021)

Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
por: Juul, Sandra E., et al.
Publicado: (2022)

Patterns of Infections among Extremely Preterm Infants
por: Perez, Krystle, et al.
Publicado: (2023)

Troponin I Levels in Neonatal Hypoxic–Ischemic Encephalopathy Are Related to Cardiopulmonary Comorbidity and Neurodevelopmental Outcomes
por: Lee, Inn-Chi, et al.
Publicado: (2021)

Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)

Preterm Hypoxic–Ischemic Encephalopathy
por: Gopagondanahalli, Krishna Revanna, et al.
Publicado: (2016)

Efficacy of erythropoietin alone in treatment of neonates with hypoxic-ischemic encephalopathy: A protocol for systematic review and meta-analysis
por: Yang, Guang, et al.
Publicado: (2021)

Early Post-cooling Brain Magnetic Resonance for the Prediction of Neurodevelopmental Outcome in Newborns with Hypoxic–Ischemic Encephalopathy
por: Mastrangelo, Mario, et al.
Publicado: (2019)

Predictive Values of Location and Volumetric MRI Injury Patterns for Neurodevelopmental Outcomes in Hypoxic-Ischemic Encephalopathy Neonates
por: Chang, Peter D., et al.
Publicado: (2020)

Association between newborn screening analytes and hypoxic ischemic encephalopathy
por: Wilson, Lindsay A., et al.
Publicado: (2019)

Inflammatory responses in hypoxic ischemic encephalopathy
por: Liu, Fudong, et al.
Publicado: (2013)

Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
por: Douglas-Escobar, Martha, et al.
Publicado: (2012)

Molecular chaperones and hypoxic-ischemic encephalopathy
por: Hua, Cong, et al.
Publicado: (2017)

Accounting for Nulliparity in the Prediction of Hypoxic-Ischemic Encephalopathy Using Cardiotocography
por: Vargas-Calixto, Johann, et al.
Publicado: (2023)

Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility
por: Nonomura, Miho, et al.
Publicado: (2019)

Association of cerebral metabolic rate following therapeutic hypothermia with 18-month neurodevelopmental outcomes after neonatal hypoxic ischemic encephalopathy
por: Sutin, Jason, et al.
Publicado: (2023)

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
por: Taniguchi, Hidetoshi, et al.
Publicado: (2008)

Impact of Seizure Burden in Hypoxic Ischemic Encephalopathy
por: Pardo, Andrea C.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hr2vjqensqivfi1cqbtstd2hel